Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 4/20 | 0.43 |
| ▸ | CDK2 | P24941 | 13/20 | 0.39 |
| ▸ | CDK1 | P06493 | 5/20 | 0.39 |
| ▸ | CDK4 | P11802 | 2/20 | 0.39 |
| ▸ | CCND1 | P24385 | 2/20 | 0.39 |
| ▸ | CCND3 | P30281 | 1/20 | 0.39 |
| ▸ | CDK6 | Q00534 | 1/20 | 0.39 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.39 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22650781 | 0.87 | IKBKB (0.39) | EGFRCDK2CDK1CDK4CCND1 | |
| SCHEMBL22650541 | 0.78 | EGFR (0.36) | EGFRCDK2CDK4CCND1 | |
| SCHEMBL22650574 | 0.78 | CDK4 (0.43) | CDK2CDK1CDK4CCND1CCND3 | |
| SCHEMBL22650631 | 0.77 | EGFR (0.43) | EGFRCDK2 | |
| SCHEMBL29491142 | 0.76 | CDK4 (0.44) | EGFRCDK2CDK1CDK4CCND1 | |
| SCHEMBL22650935 | 0.76 | CDK4 (0.44) | EGFRCDK2CDK1CDK4CCND1 | |
| SCHEMBL22635855 | 0.76 | CDK4 (0.44) | EGFRCDK2CDK1CDK4CCND1 | |
| SCHEMBL22650933 | 0.76 | CDK4 (0.44) | EGFRCDK2CDK1CDK4CCND1 | |
| SCHEMBL22650623 | 0.75 | CDK2 (0.52) | CDK2CDK1CDK4CCND1CCND3 | |
| SCHEMBL22650578 | 0.75 | IKBKB (0.35) | EGFRCDK2CDK1CCNB1KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020224568-A1 | CDK INHIBITORS | QILU REGOR THERAPEUTICS INC. (CN) | 2020-11-12 | — | — | WO | disclosed |